The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases
Phase 3
- Conditions
- COVID 19.U07.1
- Registration Number
- IRCT20200415047089N1
- Lead Sponsor
- Saveh University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
suspected COVID-19 outpatient cases according to the flowchart for the Diagnosis and Treatment of 19 COVID Diseases of the Ministry of Health, Age between 18 and 65 years, Signing a Informed Consent
Exclusion Criteria
Pregnancy, Breastfeeding, history of drug allergy, complications of bacterial infection, underlying diseases (heart disease, renal failure, liver failure, primary vascular and cardiovascular disease, chronic lung disease, malignancy, endocrine and metabolic diseases, thyroid disorders) Immune system defects, encephalopathy, neuropathy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of clinical symptoms. Timepoint: Start of study and 7 days after study. Method of measurement: Questionnaire - telephone follow-up and.
- Secondary Outcome Measures
Name Time Method Hospitalizations. Timepoint: 7 and 14 days after study. Method of measurement: Telephone follow up.